Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE) Position Reduced by Gerber Kawasaki Wealth & Investment Management

Share on StockTwits

Gerber Kawasaki Wealth & Investment Management trimmed its holdings in shares of Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE) by 61.5% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 4,582 shares of the company’s stock after selling 7,328 shares during the period. Gerber Kawasaki Wealth & Investment Management owned 0.12% of Invesco Dynamic Biotechnology & Genome ETF worth $266,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. JPMorgan Chase & Co. acquired a new stake in shares of Invesco Dynamic Biotechnology & Genome ETF in the 1st quarter worth about $28,000. TCI Wealth Advisors Inc. acquired a new stake in shares of Invesco Dynamic Biotechnology & Genome ETF in the 2nd quarter worth about $45,000. HighTower Advisors LLC increased its holdings in shares of Invesco Dynamic Biotechnology & Genome ETF by 12.4% in the 1st quarter. HighTower Advisors LLC now owns 4,407 shares of the company’s stock worth $206,000 after acquiring an additional 487 shares during the period. WBH Advisory Inc. acquired a new position in Invesco Dynamic Biotechnology & Genome ETF during the 2nd quarter valued at about $210,000. Finally, Citigroup Inc. increased its stake in Invesco Dynamic Biotechnology & Genome ETF by 7.1% during the 1st quarter. Citigroup Inc. now owns 5,694 shares of the company’s stock valued at $265,000 after buying an additional 375 shares during the period.

Invesco Dynamic Biotechnology & Genome ETF stock traded down $0.39 during trading hours on Thursday, hitting $60.11. 22 shares of the company traded hands, compared to its average volume of 11,992. The firm’s 50-day simple moving average is $60.11 and its two-hundred day simple moving average is $54.70. Invesco Dynamic Biotechnology & Genome ETF has a 1-year low of $38.08 and a 1-year high of $63.40.

Invesco Dynamic Biotechnology & Genome ETF Company Profile

PowerShares Dynamic Biotechnology & Genome Portfolio (the Fund) is based on the Dynamic Biotechnology & Genome Intellidex Index (the Index). The Fund seeks investment results that correspond generally to the price and yield of the Index. The Index consists of stocks of 30 the United States biotechnology and genome companies.

See Also: Investing strategies using the yield curve

Institutional Ownership by Quarter for Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE)

Receive News & Ratings for Invesco Dynamic Biotechnology & Genome ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Dynamic Biotechnology & Genome ETF and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply